Key Insights

Highlights

Success Rate

98% trial completion (above average)

Research Maturity

60 completed trials (61% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

1.0%

1 terminated out of 98 trials

Success Rate

98.4%

+11.9% vs benchmark

Late-Stage Pipeline

6%

6 trials in Phase 3/4

Results Transparency

17%

10 of 60 completed with results

Key Signals

10 with results98% success

Data Visualizations

Phase Distribution

66Total
Not Applicable (49)
Early P 1 (1)
P 1 (4)
P 2 (6)
P 3 (4)
P 4 (2)

Trial Status

Completed60
Unknown19
Recruiting10
Active Not Recruiting3
Enrolling By Invitation3
Suspended1

Trial Success Rate

98.4%

Benchmark: 86.5%

Based on 60 completed trials

Clinical Trials (98)

Showing 20 of 20 trials
NCT05977296Not ApplicableCompleted

Obstructive Sleep Apnea (OSA), Oral Frailty, Dysphagia, Continuous Positive Airway Pressure (CPAP)

NCT06540716Not ApplicableCompleted

Inspire Singapore Study

NCT05094271Phase 1CompletedPrimary

Is Obstructive Sleep Apnea Important in the Development of Alzheimer's Disease?

NCT07572500Not ApplicableWithdrawn

MEA DPA Hypoxic Event Reductions

NCT05254431Not ApplicableRecruiting

The Effect of Interval Exercise on Functional Outcomes in Veterans With COPD and OSA

NCT05562388Not ApplicableCompleted

Mandibular Advancement Device and Changes in Nocturia

NCT07370376CompletedPrimary

Ultrasonographic of Diaphragmatic Function in Obstructive Sleep Apnea

NCT06910930Not ApplicableRecruitingPrimary

Impact of Muscle Training Device on Non-Severe OSA

NCT07301762Not ApplicableEnrolling By Invitation

Automated Manual Lymphatic Drainage Therapy to Improve Glymphatic Function in OSA Patients

NCT05944965Phase 1CompletedPrimary

Pharyngeal Muscle Control Mechanisms of Atomoxetine-plus-oxybutynin in Obstructive Sleep Apnea

NCT05813275Phase 3CompletedPrimary

Parallel-Arm Study to Compare AD109 to Placebo With Patients With OSA (SynAIRgy Study)

NCT05811247Phase 3CompletedPrimary

Parallel Arm Trial of AD109 and Placebo With Patients With OSA (LunAIRo)

NCT05395390Not ApplicableCompletedPrimary

COPD Circuit Exercise

NCT06649045Phase 3Active Not RecruitingPrimary

A Master Protocol for Orforglipron in Participants With Obstructive Sleep Apnea and Obesity or Overweight

NCT05763329Phase 1CompletedPrimary

Effects of Lemborexant as a Treatment for Moderate-to-severe OSA Patients With Low Arousal Threshold

NCT05960175Not ApplicableRecruitingPrimary

Impact of Patient Involvement in Alerts Management of Telemonitoring CPAP

NCT07060079Recruiting

The Use of Entropy to Assess Sleep Disordered Breathing in Chronic Respiratory Disease

NCT06916858Not ApplicableActive Not RecruitingPrimary

Prevalence of OSA and Diagnostic Accuracy of Type 3 Home Sleep Test in Difficult-to-treat Asthma

NCT06092710Completed

Predictability of OSA With a Subjective Screening Scale (OSASSS1)

NCT06566820Phase 3Enrolling By InvitationPrimary

Continuation Protocol for Obstructive Sleep Apnea (OSA)

Scroll to load more

Research Network

Activity Timeline